Melanoma, Experimental

"Melanoma, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.

Descriptor ID	D008546
MeSH Number(s)	C04.557.465.625.650.510.525 C04.557.580.625.650.510.525 C04.557.665.510.525 C04.619.600 E05.598.500.496.937
Concept/Terms	Melanoma, Experimental Melanoma, Experimental Melanomas, Experimental Experimental Melanoma Experimental Melanomas Melanoma, Harding-Passey Melanoma, Harding-Passey Harding-Passey Melanoma Melanoma, Harding Passey Harding Passey Melanoma Melanoma, B16 Melanoma, B16 B16 Melanomas Melanomas, B16 B16 Melanoma Melanoma, Cloudman S91 Melanoma, Cloudman S91 Cloudman S91 Melanoma S91 Melanoma, Cloudman

Below are MeSH descriptors whose meaning is more general than "Melanoma, Experimental".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Germ Cell and Embryonal [C04.557.465]
Neuroectodermal Tumors [C04.557.465.625]
Neuroendocrine Tumors [C04.557.465.625.650]
Melanoma [C04.557.465.625.650.510]
Melanoma, Experimental [C04.557.465.625.650.510.525]
Neoplasms, Nerve Tissue [C04.557.580]
Neuroectodermal Tumors [C04.557.580.625]
Neuroendocrine Tumors [C04.557.580.625.650]
Melanoma [C04.557.580.625.650.510]
Melanoma, Experimental [C04.557.580.625.650.510.525]
Nevi and Melanomas [C04.557.665]
Melanoma [C04.557.665.510]
Melanoma, Experimental [C04.557.665.510.525]
Neoplasms, Experimental [C04.619]
Melanoma, Experimental [C04.619.600]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Models, Animal [E05.598]
Disease Models, Animal [E05.598.500]
Neoplasms, Experimental [E05.598.500.496]
Melanoma, Experimental [E05.598.500.496.937]

Below are MeSH descriptors whose meaning is related to "Melanoma, Experimental".

Below are MeSH descriptors whose meaning is more specific than "Melanoma, Experimental".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Melanoma, Experimental" by people in this website by year, and whether "Melanoma, Experimental" was a major or minor topic of these publications.

Bar chart showing 8 publications over 8 distinct years, with a maximum of 1 publications in 1996 and 1999 and 2008 and 2009 and 2010 and 2013 and 2018 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1999	1	0	1
2008	0	1	1
2009	1	0	1
2010	0	1	1
2013	1	0	1
2018	0	1	1
2021	1	0	1

Below are the most recent publications written about "Melanoma, Experimental" by people in Profiles.

Tewary P, Brooks AD, Xu YM, Wijeratne EMK, Babyak AL, Back TC, Chari R, Evans CN, Henrich CJ, Meyer TJ, Edmondson EF, de Aquino MTP, Kanagasabai T, Shanker A, Gunatilaka AAL, Sayers TJ. Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Res. 2021 06 15; 81(12):3374-3386.

View in: PubMed
Ushigusa T, Koyama Y, Ito T, Watanabe K, Chambers JK, Hasegawa A, Uchida K, Kanegi R, Hatoya S, Inaba T, Sugiura K. Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen. J Vet Med Sci. 2018 Feb 09; 80(2):190-196.

View in: PubMed
Thompson S, Ballard B, Jiang Z, Revskaya E, Sisay N, Miller WH, Cutler CS, Dadachova E, Francesconi LC. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel. Nucl Med Biol. 2014 Mar; 41(3):276-81.

View in: PubMed
Shirasugi I, Kamada M, Matsui T, Sakakibara Y, Liu MC, Suiko M. Sulforaphane inhibited melanin synthesis by regulating tyrosinase gene expression in B16 mouse melanoma cells. Biosci Biotechnol Biochem. 2010; 74(3):579-82.

View in: PubMed
Dias BR, Rodrigues EG, Nimrichter L, Nakayasu ES, Almeida IC, Travassos LR. Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3. Mol Cancer. 2009 Dec 07; 8:116.

View in: PubMed
Francia G, Emmenegger U, Lee CR, Shaked Y, Folkins C, Mossoba M, Medin JA, Man S, Zhu Z, Witte L, Kerbel RS. Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines. Mol Cancer Ther. 2008 Oct; 7(10):3452-9.

View in: PubMed
Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 2003 Mar 15; 63(6):1270-9.

View in: PubMed
Francia G, Poulsom R, Hanby AM, Mitchell SD, Williams G, Mckee P, Hart IR. Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells. Int J Cancer. 1999 Aug 27; 82(5):709-13.

View in: PubMed
Francia G, Mitchell SD, Moss SE, Hanby AM, Marshall JF, Hart IR. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res. 1996 Sep 01; 56(17):3855-8.

View in: PubMed
Sanborn G, Niederkorn J, Kan-Mitchell J, Albert D. Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine. Graefes Arch Clin Exp Ophthalmol. 1992; 230(1):72-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals